Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.827
-0.005 (-0.60%)
At close: Jun 26, 2026, 4:00 PM EDT
0.831
+0.004 (0.47%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Traws Pharma Employees
As of December 31, 2025, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$390,429
Profits / Employee
-$1,987,143
Market Cap
12.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Passage Bio | 24 |
| BioLineRx | 24 |
| Jasper Therapeutics | 22 |
| BioCardia | 21 |
| IN8bio | 18 |
| SeaStar Medical Holding | 17 |
| BioVie | 13 |
TRAW News
- 5 days ago - Traws Pharma provides update on tivoxavir marboxil program - TheFly
- 5 days ago - Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program - GlobeNewsWire
- 9 days ago - Traws Pharma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 12 days ago - Traws Pharma downgraded to Neutral from Buy at Ladenburg - TheFly
- 15 days ago - Traws Pharma influenza challenge study deferred following MHRA review - TheFly
- 15 days ago - Traws Pharma Provides Regulatory Update on Influenza Program - GlobeNewsWire
- 4 weeks ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - Traws Pharma Proxy statement: Proxy filing - Filings